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Abstract: 
Telmisartan, a widely prescribed antihypertensive drug belongs to class II under BCS and exhibit low and variable oral 
bioavailability due to its poor aqueous solubility. As such it needs enhancement in the dissolution rate and bioavailability to 
derive its maximum therapeutic efficacy. The objective of the present study is to prepare and evaluate solid dispersions of 
Telmisartan in Starch 1500 and Soluplus alone and in combination for enhancing the dissolution rate and dissolution efficiency 
of Telmisartan. The individual and combined effects of the two carriers, Starch 1500 and Soluplus in enhancing the dissolution 
rate and dissolution efficiency of Telmisartan were evaluated in a 22 factorial study. Solid dispersions of Telmisartan in Starch 
1500 alone were prepared using four ratios of drug: carrier namely 2:1, 1:1, 1:2 and 1:3 by solvent evaporation method. Solid 
dispersions of Telmisartan in Soluplus alone were prepared at three concentrations namely 0.5, 1.0 and 2% by common solvent 
method. Solid dispersions of Telmisartan in combined carriers namely Starch 1500 and Soluplus were prepared as per 22 
factorial design. All the solid dispersions prepared were evaluated for drug content uniformity, dissolution rate and dissolution 
efficiency in comparison to Telmisartan pure drug. 
The dissolution rate and dissolution efficiency of Telmisartan could be significantly enhanced by solid dispersion in Starch 1500 
and Soluplus alone and in combination.  The individual and combined effects of Starch 1500 and Soluplus in enhancing the 
dissolution rate and dissolution efficiency of Telmisartan are highly significant (P < 0.01). Soluplus gave significant 
enhancement in the dissolution rate of Telmisartan at very low concentrations where as a large proportion of Starch 1500 is 
required for a similar enhancement in the dissolution rate of Telmisartan. Combination of Starch 1500 and Soluplus resulted in a 
much higher enhancement in the dissolution rate and dissolution efficiency of Telmisartan than is possible with them 
individually. Combination of Starch 1500 and Soluplus is recommended for enhancing the dissolution rate and dissolution 
efficiency of Telmisartan.  
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INTRODUCTION: 
About 95% of all new potential therapeutic drugs 
(APIs) exhibit low and variable oral bioavailability 
due to their poor aqueous solubility at physiological 
pH and consequent low dissolution rate. These drugs 
are classified as class II drugs under BCS with low 
solubility and high permeability characters and pose 
challenging problems in their pharmaceutical product 
development process. Telmisartan, a widely 
prescribed antihypertensive drug belongs to class II 
under BCS and exhibit low and variable oral 
bioavailability due to its poor aqueous solubility. As 
such it needs enhancement in the dissolution rate and 
bioavailability to derive its maximum therapeutic 
efficacy. 
Several techniques [1] such as micronization, 
cyclodextrin complexation, use of surfactants and 
solubilizers, solid dispersion in water soluble and 
dispersible carriers, use of salts, prodrugs and 
polymorphs which exhibit high solubility , micro 
emulsions and self-emulsifying micro and nano 
disperse systems have been used to enhance the 
solubility, dissolution rate and bioavailability of 
poorly soluble drugs. Among the various approaches, 
solid dispersion [2,3] in water soluble and water 
dispersible excipients is a simple, industrially useful 
approach for enhancing the solubility, dissolution rate 
and bioavailability of poorly soluble drugs. In solid 
dispersions the poorly soluble drug is dispersed in an 
inert water-soluble carrier such as urea, polyethylene 
glycol, poly vinyl pyrrolidone and surfactants at solid 
state. In the case of solvent deposited dispersions the 
drug is deposited in minuscular form on an inert 
water insoluble excipient such as silica gel, starch 
and modified starches at solid state. 
 Starch 1500 is a modified starch namely 
Pregelatinised starch used in tablets as diluent and 
directly compressible vehicle. It is also used as a 
carrier in solid dispersions in a few studies [4-7]. In 
the present study Starch 1500 is evaluated as carrier 
for solid dispersions for enhancing the dissolution 
rate of Telmisartan. 
Soluplus is a polymeric solubiliser with an 
amphiphilic chemical nature, which was particularly 
developed for solid solutions. Soluplus is polyvinyl 
caprolactam - polyvinyl acetate - polyethylene glycol 
graft co-polymer. Soluplus increased the solubility 
and enhanced the bioavailability of actives in solid 
solutions. Itraconazole and fenofibrate showed 
significant increase in the bioavailability with 
Soluplus [8]. The solubility and dissolution rate of 
valsartan was effectively enhanced by using Soluplus 
in the form of solid dispersions [9]. 
The objective of the present study is to prepare and 
evaluate solid dispersions of Telmisartan in Starch 
1500 and Soluplus alone and in combination for 
enhancing the dissolution rate and dissolution 
efficiency of Telmisartan. The individual and 
combined effects of the two carriers, Starch 1500 and 
Soluplus in enhancing the dissolution rate and 
dissolution efficiency of Telmisartan were evaluated 
in a 22 factorial study. 
 
EXPERIMENTAL: 
Materials: 
Telmisartan was a gift sample from M/s Hetero 
Drugs Ltd., Hyderabad. Soluplus and Starch 1500 
were procured from commercial sources. All other 
materials used were of pharmacopoeial grade. 
Estimation of Telmisartan: 
An UV Spectrophotometric method based on the 
measurement of absorbance at 296 nm in phosphate 
buffer of pH 7.5 was used for the estimation of 
Telmisartan. The method was validated for linearity, 
accuracy, precision and interference. The method 
obeyed Beer’s law in the concentration range of 0 - 
10 µg/ ml. When a standard drug solution was 
repeatedly assayed (n=6), the relative error and 
coefficient of variance were found to be 0.65% and 
1.4% respectively. No interference by the excipients 
used in the study was observed. 
Preparation of Solid Dispersions in Starch 1500 
 Solid dispersions of Telmisartan in Starch 1500 
using various ratios of drug: carrier were prepared by 
solvent evaporation method. The required quantity of 
Telmisartan was dissolved in ethanol (10 ml) to get a 
clear solution in a dry mortar.  Starch 1500 was 
added to the drug solution in the mortar and mixed. 
The mixture was triturated continuously for 20 min to 
evaporate the solvent. Trituration was continued until 
a dry mass was obtained. The mass obtained was 
further dried at 500 C for 1 h in hot air oven. The 
dried product was powdered and passed through 
mesh no 100 in each case. 
Preparation of Solid Dispersions in Soluplus: 
Solid dispersions of Telmisartan in different 
concentrations of Soluplus were prepared by 
common solvent method. The required quantity of 
Telmisartan and Soluplus were dissolved in ethanol 
(10 ml) to get a clear solution in a dry mortar. The 
solution was triturated continuously for 20 min to 
evaporate the solvent. Trituration was continued until 
a dry mass was obtained. The mass obtained was 
further dried at 500 C for 1 h in hot air oven. The 
dried product was powdered and passed through 
mesh no 100 in each case. 
 
Preparation of Solid Dispersions in Combined 
Carriers: 
Solid dispersions of Telmisartan in Starch 1500 and 
Soluplus as per 22 factorial design were prepared by 
kneading method. The required quantities of drug and 
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Soluplus were dissolved in the solvent ethanol to get 
a clear solution in a dry mortar. Starch 1500 was 
added to the drug- surfactant solution in the motor 
and mixed. The mixture was kneaded for 30 min by 
continuous trituration. Small volume of the solvent 
was added to maintain the mixture as thick slurry 
during kneading process. Trituration was continued 
until a dry mass was obtained. The mass obtained 
was further dried at 50C for 1 hour in a hot air oven. 
The dried product was powdered and passed through 
mesh no. 100 in each case.  
Estimation of Drug Content of Solid Dispersions: 
From each batch four samples of solid dispersion 
equivalent to 20 mg of the medicament was taken 
into a 100 ml conical flask and extracted with 3 x 10 
ml quantities of ethanol.  The ethanolic extracts were 
filtered and collected into 50 ml volumetric flask and 
the volume was made up to 50 ml with ethanol.  The 
solution was subsequently diluted with Phosphate 
buffer pH 7.5 and assayed for the Telmisartan content 
at 296 nm. 
Dissolution Rate Study: 
Dissolution rate of Telmisartan from various solid 
dispersions prepared was studied in water (900 ml) 
employing USP 8 station Dissolution Rate Test 
Apparatus (M/s Lab India Disso 8000) with a paddle 
stirrer at 50rpm. A temperature of 37±1°C was 
maintained throughout the study. Telmisartan or its 
solid dispersion equivalent to 20 mg of Telmisartan 
was used in the test. Samples of dissolution fluid (5 
ml) were withdrawn through a filter (0.45 µm) at 
different intervals of time, suitably diluted and 
assayed for Telmisartan at 296 nm. The dissolution 
fluid withdrawn at each sampling time was replaced 
with fresh dissolution fluid and suitable correction is 
made in calculating the amount of drug dissolved. All 
dissolution rate experiments were conducted in 
triplicate (n=3). 
 
 
RESULTS AND DISCUSSION: 
The objective of the present study is to prepare and 
evaluate solid dispersions of Telmisartan in Starch 
1500 and Soluplus alone and in combination for 
enhancing the dissolution rate and dissolution 
efficiency of Telmisartan, a BCS class II drug. Solid 
dispersions of Telmisartan in Starch 1500 alone were 
prepared using four ratios of drug: carrier namely 2:1, 
1:1, 1:2, and 1:3 by solvent evaporation method. 
Solid dispersions of Telmisartan in Soluplus alone 
were prepared using three concentrations of carrier 
namely 0.5, 1.0 and 2% by common solvent method.  
Solid dispersions of Telmisartan in combined carriers 
namely Starch 1500 and Soluplus were prepared as 
per 22 factorial design by kneading method with a 
view to evaluate the individual main effects and 
combined (interaction) effects of Starch 1500 (factor 
A) and Soluplus (factor B) on the dissolution rate and 
dissolution efficiency (DE30) of Telmisartan. For this 
purpose two levels of Starch 1500 (0 and 1:2 ratio of 
drug : carrier) and two levels of Soluplus ( 0 and 1%) 
were selected and the corresponding four treatments 
involved in the 22 factorial study were Telmisartan 
pure drug (1); Telmisartan - Starch 1500 (1:2) solid 
dispersion (a); Telmisartan - Soluplus (1.0%) solid 
dispersion (b) and Telmisartan - Starch 1500 (1:2) - 
Soluplus (1.0%) solid dispersion (ab). The above 
mentioned solid dispersions were prepared by 
kneading method. 
All the solid dispersions prepared were found to be 
fine and free flowing powders. Low C.V (< 1.0%) in 
the percent drug content indicated uniformity of drug 
content in each batch of solid dispersions prepared. 
The dissolution of Telmisartan as such and from 
various solid dispersions was studied in water. The 
dissolution profiles of various solid dispersions 
prepared are shown in Figs.1-3.The dissolution 
parameters of Telmisartan and its solid dispersions 
prepared are given in Tables 1 and 2. 
Table 1: Dissolution Parameters of Telmisartan in Starch 1500 and Soluplus 
SD   System PD10 (%) K1× 10
2(min -1) Increase in K1 (No of folds)  DE30(%) 
1 T 47.4 6.45 - 41.1 
2 T:St(2:1) 69.3 15.45 2.40 71.3 
3 T:St(1:1) 82.2 30.2 4.68 76.1 
4 T:St(1:2) 91.6 42.1 6.52 79.8 
5 T:St(1:3) 98.6 48.2 7.47 84.2 
6   T:Sol (0.5%) 58.5 9.4 1.45 52.1 
7 T:Sol (1%) 68.4 16.16 2.50 65.5 
8 T:Sol (2%) 97.2 35.8 
5.55 
85.5 
 
 
SD – Solid dipersion ; T- Telmisartan ;St-Starch 1500 ;   Sol - Soluplus             
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Table 2: Dissolution Parameters of Telmisartan Solid Dispersions in Starch 1500 and Soluplus Prepared as 
per 22- Factorial Design 
 
SD  System PD10 (%) K1x102 min-1 
Increase in K1 
(No. of folds) 
DE30 (%) 
Increase in 
DE30 (No. of 
folds) 
1 T 47.4 6.45 --- 41.09 --- 
a T-St (1:2) 91.6 42.1 6.53 79.8 1.94 
b T-Sol (1%) 68.4 16.16 2.50 65.45 1.59 
ab    T-St (1:2) - Sol (1%) 99.2 52.6 8.15 94.6 2.30 
SD -Solid dipersion; T- Telmisartan; St-Starch 1500;   Sol - Soluplus   
 
Fig .1: Dissolution Profiles of Telmisartan and Its Solid Dispersions in Starch 
 
 Fig. 2: Dissolution Profiles of Telmisartan and Its Solid Dispersions in Soluplus 1500 
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Fig. 3: Dissolution Profiles of Telmisartan Solid Dispersions in Starch 1500 and Soluplus Prepared as 
per 22- Factorial Design 
 All solid dispersions prepared gave rapid and higher 
dissolution of Telmisartan when compared to 
Telmisartan pure drug. The dissolution data were 
analyzed as per zero order and first order kinetics in 
each case. The correlation coefficient (r) values were 
higher in the first order model than in zero order 
model indicating that the dissolution of Telmisartan 
as such and from its solid dispersions followed first 
order kinetics. The correlation coefficient (r) values 
in the first order model were found to be in the range 
0.910 - 0.980. The corresponding dissolution rate 
(K1) values of various products were estimated. 
Dissolution Efficiency (DE30) values were calculated 
as described by Khan [10].The dissolution parameters 
of various solid dispersions are summarized in Tables 
1 and 2.   
All dissolution parameters (PD10, K1 and DE30) 
indicated rapid and higher dissolution of Telmisartan 
from all solid dispersions when compared to 
Telmisartan. With both Starch 1500 and Soluplus the 
dissolution rate and dissolution efficiency of 
Telmisartan was increased as the concentration of 
carrier in the solid dispersion was increased. In the 
case of Starch 1500 the dissolution rate was increased 
by 2.4, 4.68, 6.52 and 7.47 Folds respectively, in the 
case of SDs prepared at drug: carrier ratio of 2:1, 1: 
1, 1:2 and 1:3. In the case of SDs prepared with 
Soluplus, 1.45, 2.50 and 5.55 folds increase in the 
dissolution rate was observed at 0.5, 1.0 and 2.0 
percent concentration of carrier. In the case of 
Soluplus (Surfactant) a low concentration of carrier 
gave a significant increase in the dissolution rate 
when compared to Starch 1500. 
The results of factorial study given in Table 2 
indicated that the dissolution rate and dissolution 
efficiency of Telmisartan were markedly increased 
by solid dispersion in Starch 1500 and Soluplus alone 
and in combination. Analysis of Variance (ANOVA) 
indicated that the Individual and combined effects of 
Starch 1500 (Factor A) and Soluplus (Factor B) are 
highly significant (P< 0.01). Solid dispersion in 
Starch 1500 alone gave a 6.53 fold increase in the 
dissolution rate of Telmisartan at a drug: carrier ratio 
of 1:2. Soluplus at 1.0 percent concentration gave a 
2.50 fold increase in the dissolution rate of 
Telmisartan whereas in combination they (dispersion 
ab) gave a 8.15 fold increase in the dissolution rate of 
Telmisartan. In combination Starch 1500 and 
Soluplus gave higher enhancement in the dissolution 
rate of Telmisartan than is possible with them 
individually. The higher enhancement in the 
dissolution rate is due to the combined effects of the 
two carriers.  The drug is deposited in miniscular 
form on the carrier Starch 1500 particles, which 
increases the surface area of drug resulting in the 
enhancement of Dissolution rate of Telmisartan.  
Soluplus being a surfactant increases the wettability 
of drug particles by reducing interfacial tension and 
thus increases the dissolution rate of Telmisartan. 
Hence a combination of Starch 1500 and Soluplus are 
recommended for enhancing the dissolution rate and 
dissolution efficiency of Telmisartan, a BCS class II 
drug..  
 
CONCLUSIONS: 
1.  The dissolution rate and dissolution efficiency of 
Telmisartan could be significantly enhanced by solid 
dispersion in Starch 1500 and Soluplus alone and in 
combination.  
2. The individual and combined effects of Starch 
1500 and Soluplus in enhancing the dissolution rate 
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and dissolution efficiency of Telmisartan are highly 
significant (P < 0.01) . 
3. Soluplus gave significant enhancement in the 
dissolution rate of Telmisartan at very low 
concentrations; where as a large proportion of Starch 
1500 is required for a similar enhancement in the 
dissolution rate of Telmisartan.  
4. Combination of Starch 1500 and Soluplus resulted 
in a much higher enhancement in the dissolution rate 
and dissolution efficiency of Telmisartan than is 
possible with them individually. 
5. Combination of Starch 1500 and Soluplus is 
recommended for enhancing the dissolution rate and 
dissolution efficiency of Telmisartan.  
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